vs
纽约时报公司（NYT）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是纽约时报公司的1.8倍（$1.4B vs $802.3M），纽约时报公司净利率更高（16.2% vs 3.6%，领先12.6%），通用电气医疗同比增速更快（12.2% vs 10.4%），纽约时报公司自由现金流更多（$157.6M vs $130.2M），过去两年纽约时报公司的营收复合增速更高（16.2% vs 13.0%）
纽约时报公司是美国知名大众传媒企业，总部位于纽约市曼哈顿的纽约时报大厦，旗下核心出版产品包括《纽约时报》及其国际版等系列刊物，同时运营多元媒体资产，在全球新闻传媒领域拥有较高知名度。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
NYT vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.8倍
$802.3M
营收增速更快
OPCH
高出1.8%
10.4%
净利率更高
NYT
高出12.6%
3.6%
自由现金流更多
NYT
多$27.4M
$130.2M
两年增速更快
NYT
近两年复合增速
13.0%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $802.3M | $1.4B |
| 净利润 | $129.8M | $51.8M |
| 毛利率 | — | 19.0% |
| 营业利润率 | 20.1% | 5.9% |
| 净利率 | 16.2% | 3.6% |
| 营收同比 | 10.4% | 12.2% |
| 净利润同比 | 4.9% | -3.8% |
| 每股收益（稀释后） | $0.79 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NYTOPCH
| Q4 25 | $802.3M | — | ||
| Q3 25 | $700.8M | $1.4B | ||
| Q2 25 | $685.9M | $1.4B | ||
| Q1 25 | $635.9M | $1.3B | ||
| Q4 24 | $726.6M | $1.3B | ||
| Q3 24 | $640.2M | $1.3B | ||
| Q2 24 | $625.1M | $1.2B | ||
| Q1 24 | $594.0M | $1.1B |
净利润NYTOPCH
| Q4 25 | $129.8M | — | ||
| Q3 25 | $81.6M | $51.8M | ||
| Q2 25 | $82.9M | $50.5M | ||
| Q1 25 | $49.6M | $46.7M | ||
| Q4 24 | $123.7M | $60.1M | ||
| Q3 24 | $64.1M | $53.9M | ||
| Q2 24 | $65.5M | $53.0M | ||
| Q1 24 | $40.4M | $44.8M |
毛利率NYTOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 20.3% | ||
| Q1 24 | — | 20.8% |
营业利润率NYTOPCH
| Q4 25 | 20.1% | — | ||
| Q3 25 | 15.0% | 5.9% | ||
| Q2 25 | 15.5% | 5.8% | ||
| Q1 25 | 9.2% | 5.9% | ||
| Q4 24 | 20.2% | 6.9% | ||
| Q3 24 | 12.0% | 6.7% | ||
| Q2 24 | 12.7% | 6.6% | ||
| Q1 24 | 8.1% | 6.0% |
净利率NYTOPCH
| Q4 25 | 16.2% | — | ||
| Q3 25 | 11.7% | 3.6% | ||
| Q2 25 | 12.1% | 3.6% | ||
| Q1 25 | 7.8% | 3.5% | ||
| Q4 24 | 17.0% | 4.8% | ||
| Q3 24 | 10.0% | 4.2% | ||
| Q2 24 | 10.5% | 4.3% | ||
| Q1 24 | 6.8% | 3.9% |
每股收益（稀释后）NYTOPCH
| Q4 25 | $0.79 | — | ||
| Q3 25 | $0.50 | $0.32 | ||
| Q2 25 | $0.50 | $0.31 | ||
| Q1 25 | $0.30 | $0.28 | ||
| Q4 24 | $0.74 | $0.36 | ||
| Q3 24 | $0.39 | $0.31 | ||
| Q2 24 | $0.40 | $0.30 | ||
| Q1 24 | $0.24 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $642.2M | $309.8M |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $2.0B | $1.4B |
| 总资产 | $3.0B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资NYTOPCH
| Q4 25 | $642.2M | — | ||
| Q3 25 | $617.4M | $309.8M | ||
| Q2 25 | $540.2M | $198.8M | ||
| Q1 25 | $522.1M | $171.4M | ||
| Q4 24 | $565.9M | $412.6M | ||
| Q3 24 | $492.9M | $483.0M | ||
| Q2 24 | $411.4M | $376.9M | ||
| Q1 24 | $379.1M | $219.5M |
总债务NYTOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益NYTOPCH
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $1.9B | $1.4B | ||
| Q1 25 | $1.9B | $1.4B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $1.9B | $1.4B | ||
| Q2 24 | $1.8B | $1.4B | ||
| Q1 24 | $1.7B | $1.4B |
总资产NYTOPCH
| Q4 25 | $3.0B | — | ||
| Q3 25 | $2.9B | $3.5B | ||
| Q2 25 | $2.8B | $3.4B | ||
| Q1 25 | $2.7B | $3.3B | ||
| Q4 24 | $2.8B | $3.4B | ||
| Q3 24 | $2.8B | $3.4B | ||
| Q2 24 | $2.7B | $3.3B | ||
| Q1 24 | $2.6B | $3.2B |
负债/权益比NYTOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $164.2M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $157.6M | $130.2M |
| 自由现金流率自由现金流/营收 | 19.6% | 9.1% |
| 资本支出强度资本支出/营收 | 0.8% | 0.6% |
| 现金转化率经营现金流/净利润 | 1.26× | 2.69× |
| 过去12个月自由现金流最近4个季度 | $550.5M | $220.7M |
8季度趋势，按日历期对齐
经营现金流NYTOPCH
| Q4 25 | $164.2M | — | ||
| Q3 25 | $207.6M | $139.4M | ||
| Q2 25 | $113.6M | $90.3M | ||
| Q1 25 | $99.1M | $-7.2M | ||
| Q4 24 | $151.7M | $36.1M | ||
| Q3 24 | $125.5M | $160.4M | ||
| Q2 24 | $80.2M | $195.7M | ||
| Q1 24 | $53.1M | $-68.8M |
自由现金流NYTOPCH
| Q4 25 | $157.6M | — | ||
| Q3 25 | $199.7M | $130.2M | ||
| Q2 25 | $103.3M | $81.2M | ||
| Q1 25 | $89.9M | $-16.6M | ||
| Q4 24 | $143.6M | $25.8M | ||
| Q3 24 | $118.4M | $150.7M | ||
| Q2 24 | $72.6M | $185.9M | ||
| Q1 24 | $46.7M | $-74.6M |
自由现金流率NYTOPCH
| Q4 25 | 19.6% | — | ||
| Q3 25 | 28.5% | 9.1% | ||
| Q2 25 | 15.1% | 5.7% | ||
| Q1 25 | 14.1% | -1.2% | ||
| Q4 24 | 19.8% | 2.0% | ||
| Q3 24 | 18.5% | 11.8% | ||
| Q2 24 | 11.6% | 15.1% | ||
| Q1 24 | 7.9% | -6.5% |
资本支出强度NYTOPCH
| Q4 25 | 0.8% | — | ||
| Q3 25 | 1.1% | 0.6% | ||
| Q2 25 | 1.5% | 0.6% | ||
| Q1 25 | 1.5% | 0.7% | ||
| Q4 24 | 1.1% | 0.8% | ||
| Q3 24 | 1.1% | 0.8% | ||
| Q2 24 | 1.2% | 0.8% | ||
| Q1 24 | 1.1% | 0.5% |
现金转化率NYTOPCH
| Q4 25 | 1.26× | — | ||
| Q3 25 | 2.54× | 2.69× | ||
| Q2 25 | 1.37× | 1.79× | ||
| Q1 25 | 2.00× | -0.15× | ||
| Q4 24 | 1.23× | 0.60× | ||
| Q3 24 | 1.96× | 2.98× | ||
| Q2 24 | 1.22× | 3.69× | ||
| Q1 24 | 1.31× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NYT
| Subscription | $510.5M | 64% |
| Advertising | $191.7M | 24% |
| Affiliate Licensing And Other Products And Services | $100.2M | 12% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
